Home  >  Products  >  SSX5 (synovial sarcoma, X breakpoint 5 ) Blocking Peptide (the C terminal of SSX5)(100ug)
SSX5 (synovial sarcoma, X breakpoint 5 ) Blocking Peptide (the C terminal of SSX5)(100ug)

SSX5 (synovial sarcoma, X breakpoint 5 ) Blocking Peptide (the C terminal of SSX5)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SSX5 Antibody (ARP39471_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP39471
Size: 100ug
Weight: 22kDa
Gene: 6758
Format: Lyophilized powder
Target: SSX5 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas. The gene encoding SSX5 appears not to be involved in this type of chromosome translocation.
Alternative names: MGC9494
See Full Product Listings >